Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen

Advances in Experimental Medicine and Biology

Volumn 500, Issue , 2001, Pages 83-92

  Lau, Serrine S ^a   Yoon, Hae Seong ^a   Patel, Sonal K ^a   Everitt, Jeffrey I ^b   Monks, Terrence J ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; HYDROQUINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGENICITY; CELL PROLIFERATION; CELL TRANSFORMATION; CONFERENCE PAPER; HETEROZYGOSITY LOSS; HISTOLOGY; KIDNEY CARCINOMA; MUTAGENICITY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARCINOGENS; CARCINOMA, RENAL CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; GLUTATHIONE; HUMANS; HYDROQUINONES; KIDNEY; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MUTAGENS; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0035697508     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-0667-6_9     Document Type: Article

References (64)

1. The metabolism of benzene. II. The isolation of phenol, catechol, quinol and hydroxyquinol from the etheral sulphate fraction of the urine of rabbits receiving benzene orally
2. 14C]phenol
3. Glass capillary column gas chromatographic analysis of tobacco and cellulose cigarette smoke. I. Acidic fractions
4. Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice
5. The epidemiology of renal cell carcinoma. A second look
6. Epidemiology of renal-cell carcinoma
7. Monitoring tobacco smoke-induced DNA damage by 32P-postlabelling
8. Free-radical chemistry of cigarette smoke and its toxicological implications
9. Screening of tobacco smoke constituents for mutagenicity using the Ames' test
10. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97
11. Mutagenicity studies with the mouse spot test
12. Mutagenicity of cosmetics ingredients licensed by the European Communities
13. Mutagenicity of dihydroxybenzenes and dihydroxynaphthalenes for Ames Salmonella tester strains
14. Mutagenicity of benzoquinones for Ames Salmonella tester strains
15. Benzene-, catechol-, hydroquinone- and phenol-induced cell transformation, gene mutations, chromosome aberrations, aneuploidy, sister chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells
16. Cigarette smoke-induced DNA-damage: Role of hydroquinone and catechol in the formation of the oxidative DNA-adduct, 8-hydroxydeoxyguanosine
17. Linking the metabolism of hydroquinone to its nephrotoxicity and nephrocarcinogenicity
18. Mechanisms of DNA damage induced in rat hepatocytes by quinones
19. Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment
20. Modification by catechol and resorcinol of upper digestive tract carcinogenesis in rats treated with methyl-N-amylnitrosamine
21. Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S- yl)hydroquinone
22. Sequential oxidation and glutathione addition to 1,4-benzoquinone: Correlation of toxicity with increased glutathione substitution
23. Identification of multi-S-substituted conjugates of hydroquinone by HPLC-coulometric electrode array analysis and mass spectroscopy
24. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat
25. A dominant gene for renal adenomas in the rat
26. Predisposition to renal carcinoma in the Eker rat is determined by germ- line mutation of the tuberous sclerosis 2 (TSC2) gene
27. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2)
28. Molecular genetics of renal carcinogenesis
29. Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma
30. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes
31. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients
32. Hereditary renal cell carcinoma in the Eker rat: A rodent familial cancer syndrome
33. Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene
34. Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hyroquinone
35. Glutathione conjugate-mediated toxicities
36. Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant to quinol-thioether- mediated nephrotoxicity
37. Specificity of a particulate rat renal peptidase and its localization along with other enzymes of mercapturic acid synthesis
38. Preneoplastic and neoplastic lesions of rat hereditary renal cell tumors express markers of proximal and distal nephron
39. Quinol-glutathione conjugate-induced mutation spectra in the supF gene replicated in human AD293 cells and bacterial MBL50 cells
40. Application of high-pressure liquid chromatography-based analysis of DNA fragments to molecular carcinogenesis
41. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues
42. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity
43. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis
44. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus
45. Complexity of trypanosomatid endocytosis pathways revealed by Rab4 and Rab5 isoforms in Trypanosoma brucei
46. Evidence for a symmetrical requirement for Rab5-GTP in in vitro endosome-endosome fusion
47. Two distinct effectors of the small GTPase Rab5 cooperate in endocytic membrane fusion
48. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion
49. The Rab5 effector EEA1 is a core component of endosome docking
50. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes
51. The benzene metabolite, hydroquinone, induces dose-dependent hypoploidy in a human cell line
52. Detection of hyperdiploidy and breakage affecting the 1cen-1q12 region of cultured interphase human lymphocytes treated with various genotoxic agents
53. Genomic instability in multistage carcinogenesis
54. The role of receptors in multistage carcinogenesis
55. Development of a quantitative in vitro transformation assay for kidney epithelial cells
56. Role of Tuberous Sclerosis gene-2 product in cell cycle control
57. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2
58. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region
59. Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells
60. Activation of brain B-Raf protein kinase by Rap 1B small GTP-binding protein
61. Analysis of the Gs/mitogen-activated protein kinase pathway in mutant S49 cells
62. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor
63. 2 synthesis in renal epithelial cells
64. Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis